Delivery Order SPE2DB20D3101-SPE2DB24FRPA5

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,378.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,896.41 firm fixed-price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a ceiling value of $17,378.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML pharmaceutical product to the Defense Logistics Agency (DLA). The $2,896.41 firm fixed price contract has a period of performance through May 14, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,951.86, is a delivery order for the specialty medication Somatuline Depot 120 mg/0.5 mL. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through March 2025. No set-aside designation was used for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,996.51 firm fixed price delivery order is for the supply of Somatuline Depot, a prescription medication used to treat certain types of tumors. The contract has an ultimate completion date of December 20, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $5,616.51 and a completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the medical product "SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML" with a firm fixed price of $5,616.51 and a period of performance through April 9, 2025. The contract is a delivery order issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Somatuline Depot 90 mg/0.3 ml pharmaceutical products. The $6,686.67 firm-fixed-price delivery order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRPA5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,896.41 firm-fixed price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract has a completion date of July 23, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. These contracts highlight Amerisourcebergen's position as a leading supplier of pharmaceuticals and medical supplies to various federal agencies, particularly the Department of Defense and Veterans Affairs healthcare systems.

Generated 9/30/24, 4:59 PM